Differential role of αvβ3 and αvβ5 integrins in internalization and transduction efficacies of wild type and RGD4C fiber-modified adenoviruses

Virus Research

Volumn 139, Issue 1, 2009, Pages 64-73

  Majhen, Dragomira ^a   Nemet, Josip ^a   Richardson, Jennifer ^b   Gabrilovac, Jelka ^c   Hajsig, Martina ^a   Osmak, Maja ^a   Eloit, Marc ^b   Ambriović Ristov, Andreja ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^c Division of Molecular Medicine   (Croatia)

Author keywords

v 3 integrin; v 5 integrin; Adenovirus; Fiber; Internalization; RGD4C; Transduction

Indexed keywords

ADENOVIRUS VECTOR; ALPHAVBETA5 INTEGRIN; ARGINYLGLYCYLASPARTIC ACID; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; VITRONECTIN RECEPTOR;

ARTICLE; CELL CLONE; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; INTERNALIZATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; SEROTYPE; VIRUS ENTRY; WILD TYPE;

ADENOVIRIDAE; CELL LINE; CELL LINE, TUMOR; HUMANS; INTEGRIN ALPHAVBETA3; RECEPTORS, VITRONECTIN; RECOMBINANT FUSION PROTEINS; TRANSDUCTION, GENETIC; VIRUS INTERNALIZATION;

ADENOVIRIDAE; HUMAN ADENOVIRUS;

EID: 57749100094     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2008.10.004     Document Type: Article

References (47)

1. 3 and coxsackie adenovirus receptor. Int. J. Cancer 110 (2004) 660-667
2. Ambriović-Ristov A., Mercier S., and Eloit M. Shortening adenovirus type 5 fiber shaft decreases the efficiency of postbinding steps in CAR-expressing and nonexpressing cells. Virology 312 (2003) 425-433
3. Ambriović-Ristov A., and Osmak M. Integrin-mediated drug resistance. Curr. Signal Transd. Ther. 1 (2006) 227-237
4. Bai M., Harfe B., and Freimuth P. Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells. J. Virol. 67 (1993) 5198-5205
5. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., and Finberg R.W. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275 (1997) 1320-1323
6. 3 integrin mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione dependent elimination of drug induced reactive oxidative species. Mol. Pharmacol. 74 (2008) 298-306
7. Chartier C., Degryse E., Gantzer M., Dieterle A., Pavirani A., and Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70 (1996) 4805-4810
8. Colin M., Renaut L., Mailly L., and D'Halluin J.C. Factors involved in the sensitivity of different hematopoietic cell lines to infection by subgroup C adenovirus: implication for gene therapy of human lymphocytic malignancies. Virology 320 (2004) 23-39
9. Colin M., Mailly L., Rogée S., and D'Halluin J.C. Efficient species C HAdV infectivity in plasmocytic cell lines using a clathrin-independent lipid raft/caveola endocytic route. Mol. Ther. 11 (2005) 224-236
10. 1-mediated adenovirus infection is enhanced by the integrin-activating antibody TS2/16. J. Virol. 71 (1997) 6204-6207
11. 1 integrin and can be modulated by changes in beta 1 integrin function. J. Gene Med. 3 (2001) 550-559
12. Dmitriev I., Krasnykh V., Miller C.R., Wang M., Kashentseva E., Mikheeva G., Belousova N., and Curiel D.T. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J. Virol. 72 (1998) 9706-9713
13. Felding-Habermann B. Integrin adhesion receptors in tumor metastasis. Clin. Exp. Metast. 20 3 (2003) 203-213
14. Fuxe J., Liu L., Malin S., Philipson L., Collins V.P., and Petterson R.F. Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts. Int. J. Cancer 103 (2003) 723-729
15. Henning P., Magnusson M.K., Gunneriusson E., Hong S.S., Boulanger P., Nygren P.A., and Lindholm L. Genetic modification of adenovirus 5 tropism by a novel class of ligands based on a three-helix bundle scaffold derived from staphylococcal protein A. Hum. Gene Ther. 13 12 (2002) 1427-1439
16. Henning P., Andersson K.M., Frykholm K., Ali A., Magnusson M.K., Nygren P.A., Granio O., Hong S.S., Boulanger P., and Lindholm L. Tumor cell targeted gene delivery by adenovirus 5 vectors carrying knobless fibers with antibody-binding domains. Gene Ther. 12 3 (2005) 211-224
17. Henning P., Lundgren E., Carlsson M., Frykholm K., Johannisson J., Magnusson M.K., Tång E., Franqueville L., Hong S.S., Lindholm L., and Boulanger P. Adenovirus type 5 fiber knob domain has a critical role in fiber protein synthesis and encapsidation. J. Gen. Virol. 87 (2006) 3151-3160
18. Huang S., Kamata T., Takada Y., Ruggeri Z.M., and Nemerow G.R. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J. Virol. 70 (1996) 4502-4508
19. Huang X., Griffiths M., Wu J., Farese Jr. R.V., and Sheppard D. Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice. Mol. Cell Biol. 20 (2000) 755-759
20. Kanerva A., and Hemminki A. Modified adenoviruses for cancer gene therapy. Int. J. Cancer 110 (2004) 475-480
21. Krasnykh V., Dmitriev I., Mikheeva G., Miller C.R., Belousova N., and Curiel D.T. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J. Virol. 72 (1998) 1844-1852
22. Krasnykh V., Dmitriev I., Navarro J.G., Belousova N., Kashentseva E., Xiang J., Douglas J.T., and Curiel D.T. Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity. Cancer Res. 60 24 (2000) 6784-6787
23. Krasnykh V., Belousova N., Korokhov N., Mikheeva G., and Curiel D.T. Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J. Virol. 75 9 (2001) 4176-4183
24. Koivunen E., Wang B., and Ruoslahti E. Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library. J. Cell Biol. 124 3 (1994) 373-380
25. Ling W.L., Longley R.L., Brassard D.L., Armstrong L., and Schaefer E.J. Role of integrin alphaVbeta3 in the production of recombinant adenoviruses in HEK-293 cells. Gene Ther. 9 (2002) 907-914
26. 1 is an adenovirus coreceptor. J. Virol. 75 (2001) 5405-5409
27. Magnusson M.K., Hong S.S., Boulanger P., and Lindholm L. Genetic retargeting of adenovirus: novel strategy employing "deknobbing" of the fiber. J. Virol. 75 16 (2001) 7280-7289
28. Majhen D., and Ambriović-Ristov A. Adenoviral vectors-How to use them in cancer gene therapy?. Virus Res. 119 (2006) 121-133
29. Majhen D., Gabrilovac J., Eloit M., Richardson J., and Ambriović-Ristov A. Disulfide bond formation in NGR fiber-modified adenovirus is essential for retargeting to aminopeptidase N. Biochem. Biophys. Res. Commun. 348 (2006) 278-287
30. McDonald G.A., Zhu G., Li Y., Kovesdi I., Wickham T.J., and Sukhatme V.P. Efficient adenoviral gene transfer to kidney cortical vasculature utilizing a fiber modified vector. J. Gene Med. 1 2 (1999) 103-110
31. Medina-Kauwe L.K. Endocytosis of adenovirus and adenovirus capsid proteins. Adv. Drug Deliv. Rev. 55 (2003) 1485-1496
32. Meier O., and Greber U.F. Adenovirus endocytosis. J. Gene Med. 6 (2004) S152-S163
33. Mitterender N., March K.L., and Trapnell B.C. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70 (1996) 7498-7509
34. Nagel H., Maag S., Tassis A., Nestle F.O., Greber U.F., and Hemmi S. The alphavbeta5 integrin of hematopoietic and nonhematopoietic cells is a transduction receptor of RGD-4C fiber-modified adenoviruses. Gene Ther. 10 (2003) 1643-1653
35. Richardson C., Brennan P., Powell M., Prince S., Chen Y.H., Spiller O.B., and Rowe M. Susceptibility of B lymphocytes to adenovirus type 5 infection is dependent upon both coxsackie-adenovirus receptor and alphavbeta5 integrin expression. J. Gen. Virol. 86 (2005) 1669-1679
36. Salone B., Martina Y., Piersanti S., Cundari E., Cherubini G., Franqueville L., Failla C.M., Boulanger P., and Saggio I. Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5. J. Virol. 77 24 (2003) 13448-13454
37. Sambrook J., Fritsch E., and Maniatis T. Molecular Cloning Laboratory Manual. 2nd ed. (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
38. Shayakhmetov D.M., and Lieber A. Dependence of adenovirus infectivity on length of the fiber shaft domain. J. Virol. 74 (2000) 10274-10286
39. Shayakhmetov D.M., Eberly A.M., Li Z.Y., and Lieber A. Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs. J. Virol. 79 (2005) 1053-1061
40. Stockwin L.H., Matzow T., Georgopoulos N.T., Stanbridge L.J., Jones S.V., Martin I.G., Blair-Zajdel M.E., and Blair G.E. Engineered expression of the Coxsackie B and adenovirus receptor (CAR) in human dendritic cells enhances recombinant adenovirus-mediated gene transfer. J. Immunol. Methods 259 1-2 (2002) 205-215
41. 5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cells. Gene Ther. 5 (1998) 361-368
42. Tomko R.P., Xu R., and Philipson L. MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 3352-3356
43. van Beusechem V.W., van Rijswijk A.L., van Es H.H., Haisma H.J., Pinedo H.M., and Gerritsen W.R. Recombinant adenovirus vectors with knobless fibers for targeted gene transfer. Gene Ther. 7 22 (2000) 1940-1946
44. 5. J. Virol. 74 (2000) 2731-2739
45. Wickham T.J., Filardo E.J., Cheresh D.A., and Nemerow G.R. Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell. Biol. 127 (1994) 257-264
46. vβ5 promote adenovirus internalization but not virus attachment. Cell 73 (1993) 309-319
47. Wu E., Pache L., Von Seggern D.J., Mullen T.-M., Mikyas Y., Stewart P.L., and Nemerow G.R. Flexibility of the adenovirus fiber is required for efficient receptor interaction. J. Virol. 77 (2003) 7225-7235